Funder: Breakthrough T1D

Due Dates: June 10, 2025 (Letter of Intent) | July 17, 2025 (Full application)

Funding Amounts: Up to $900,000 total for up to 3 years per award; indirect costs allowed up to 10% for non-profits.

Summary: Supports research to enhance genetic risk assessment for type 1 diabetes, with emphasis on increasing predictive accuracy across diverse populations and advancing clinical translation.

Key Information: Participation in the T1D Genetic Risk Score Consortium is required for funded non-profit projects.